LASS4 Antibodies

Santa Cruz Biotechnology features a diverse variety of LASS4 monoclonal antibodies for advanced research in lipid metabolism. LASS4 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LASS4, or Longevity Assurance Gene 4, plays a crucial role in the biosynthesis of sphingolipids, which are essential components of cellular membranes and are involved in signaling pathways that regulate cell growth and apoptosis. The proper functioning of LASS4 is vital for maintaining cellular homeostasis and has implications in various diseases, including cancer and neurodegenerative disorders. Understanding LASS4 can provide insights into therapeutic targets and potential interventions. Researchers worldwide use LASS4 monoclonal antibodies to investigate cellular signaling pathways and their relationship to disease progression. Current studies focusing on LASS4 are uncovering new possibilities in drug development and therapeutic strategies. LASS4 research continues to reveal important connections between lipid metabolism and human health. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by enabling precise and reliable investigation of LASS4 in health and disease research.